Hyperthermia enhances the cytotoxicity and platinum-DNA adduct formation of lobaplatin and oxaliplatin in cultured SW 1573 cells

@article{Rietbroek2005HyperthermiaET,
  title={Hyperthermia enhances the cytotoxicity and platinum-DNA adduct formation of lobaplatin and oxaliplatin in cultured SW 1573 cells},
  author={R. Rietbroek and P. V. D. Vaart and J. Haveman and F. A. Blommaert and A. Geerdink and P. Bakker and C. Veenhof},
  journal={Journal of Cancer Research and Clinical Oncology},
  year={2005},
  volume={123},
  pages={6-12}
}
The cytotoxicity of cisplatin and cisplatin-DNA adduct formation in vitro and in vivo is clearly enhanced by hyperthermia. We investigated whether cytotoxicity and platinum-DNA adduct formation of two promising new third-generation platinum derivatives, lobaplatin [1,2-diamminomethylcyclobutane platinum(II) lactate] and oxaliplatin [oxalato-1,2-diaminocyclohexane platinum(II)], are also enhanced by hyperthermia. Cisplatin was used for comparison. SW 1573 cells were incubated with cisplatin… Expand
Thermotherapy enhances oxaliplatin-induced cytotoxicity in human colon carcinoma cells.
TLDR
Thermochemotherapy may play an important role in apoptosis via the activation of p53, Bax and the repression of Bcl-2 in Lovo cells. Expand
The influence of temperature on antiproliferative effects, cellular uptake and DNA platination of the clinically employed Pt(II)-drugs.
TLDR
The influence of temperature on dose-dependent antiproliferative effects, cellular uptake and DNA platination of these platinum-based drugs tested on MCF-7 human mammary carcinoma cell line is reported on. Expand
Thermal enhancement of oxaliplatin-induced inhibition of cell proliferation and cell cycle progression in human carcinoma cell lines
  • D. Atallah, V. Marsaud, +4 authors J. Renoir
  • Medicine
  • International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group
  • 2004
TLDR
The results of these in vitro studies suggest that hyperthermia and oxaliplatin might elicit antiproliferative effects by modulating the expression of cell cycle regulatory proteins through different signalling pathways. Expand
Cytotoxic platinum coordination compounds. DNA binding agents
Abstract Despite the widespread use of antineoplastic platinum drugs, a number of accompanying disadvantages exist. In connection with attempts to circumvent these problems new platinum compoundsExpand
Alteration of Drug Sensitivity in Human Colon Cancer Cells after Exposure to Heat: Implications for Liver Metastasis Therapy using RFA and Chemotherapy.
TLDR
An observation of a differential response to the drug and heat treatment sequences between two human colon cancer cell lines suggests that tumor heterogeneity and selection of chemotherapeutic agents need to be under consideration in the clinical setting. Expand
Thermal Enhancement of New Chemotherapeutic Agents at Moderate Hyperthermia
TLDR
Moderate hyperthermia increases the cytotoxicity of docetaxel, irinotecan, and gemcitabine on mouse fibrosarcoma. Expand
Rationale for Heating Oxaliplatin for the Intraperitoneal Treatment of Peritoneal Carcinomatosis: A Study of the Effect of Heat on Intraperitoneal Oxaliplatin Using a Murine Model
TLDR
Proportionally to the dose administered, IP oxaliplatin leads to high concentration of drug in peritoneal tissues, and heat enhancesPeritoneal tissue concentration of Oxali Platin while reducing its systemic absorption. Expand
Hyperthermia Chemo-sensitization, Chemical Thermo-sensitization and Apoptosis
TLDR
The mechanism of HT-induced apoptosis and compounds which can sensitize cancer cells to HT- induced apoptosis are discussed. Expand
A Phase I Study of Hyperthermic Isolated Hepatic Perfusion with Oxaliplatin in the Treatment of Unresectable Liver Metastases from Colorectal Cancer
TLDR
A phase I trial to evaluate the efficacy, safety, and maximum tolerated dose (MTD) of oxaliplatin delivered by hyperthermic isolated hepatic perfusion found it safe and feasible at a dose of 40 mg/m2. Expand
Optimization of Hyperthermic Intraperitoneal Chemotherapy With Oxaliplatin Plus Irinotecan at 43°C After Compete Cytoreductive Surgery: Mortality and Morbidity in 106 Consecutive Patients
TLDR
This new approach, optimized in three respects (complete cytoreduction, combination oxaliplatin with irinotecan, and high temperature) has resulted in a relatively high but acceptable incidence of adverse events considering the expected advantage for survival. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 47 REFERENCES
Drug-induced DNA modification in buccal cells of cancer patients receiving carboplatin and cisplatin combination chemotherapy, as determined by an immunocytochemical method: interindividual variation and correlation with disease response.
TLDR
It is concluded that determination of the extent of platinum-induced DNA modification might be helpful in predicting the tumor response in cancer patients. Expand
Antitumor activity of a new platinum complex, oxalato (trans-l-1,2-diaminocyclohexane)platinum (II): new experimental data.
TLDR
Antitumor activity of a new platinum complex, oxalato (trans-l-1,2-diaminocyclohexane) platinum (II) (l-OHP), was studied and showed a more prominent life-prolonging effect on a mouse leukemia L1210 than cisplatin (DDP). Expand
Effects of temperature on the interaction of cisplatin and carboplatin with cellular DNA.
TLDR
It seems that heat affects primarily the cellular uptake of cDDP and CBDCA and not their covalent binding to DNA, which results in a concentration-dependent increase in cD DP-DNA adducts. Expand
Oxalato-platinum or 1-OHP, a third-generation platinum complex: an experimental and clinical appraisal and preliminary comparison with cis-platinum and carboplatinum.
TLDR
A new platinum complex, oxalatoplatin or l-OHP, which, at the same metal dose in experimental tests is as efficient as cisplatin, and is more so at a lower metal dose than carboplatin, is described and compared with the above-mentioned platinum complexes. Expand
Correlation between cell killing by cis-diamminedichloroplatinum(II) in six mammalian cell lines and binding of a cis-diamminedichloroplatinum(II)-DNA antiserum.
TLDR
Results indicate that the initial level of cis-DDP-DNA binding measured by quantitative immunocytochemistry may be a reasonable predictor of sensitivity to this chemotherapeutic drug. Expand
Antibodies against cisplatin-modified DNA and cisplatin-modified (di) nucleotides
TLDR
NKI-A59 is the first antiserum described that is suitable for the in situ detection ofcis-DDP-DNA adducts at clinically relevant platinum levels and is suitable at the single-cell level using immunocytochemical methods. Expand
In vitro thermochemotherapy of human colon cancer cells with cis-dichlorodiammineplatinum(II) and mitomycin C.
TLDR
A significant enhancement of drug-induced cell kill by moderate hyperthermia suggests that thermochemotherapy with mitomycin C and cis-dichlorodiammineplatinum(II) should be tested clinically with both regional and total-bodyhyperthermia. Expand
Monitoring of interaction products of cis-diamminedichloroplatinum(II) and cis-diammine(1,1-cyclobutanedicarboxylato)platinum(II) with DNA in cells from platinum-treated cancer patients.
TLDR
In vitro experiments with human buccal cells and lymphocytes indicated linear relationships between DNA modification and either cis-DDP concentration or incubation time, and interpatient variation in in vitro DNA modification by cis-diammine(1,1-cyclobutanedicarboxylato)platinum(II)-treated patients was low. Expand
The synergistic effect of hyperthermia and chemotherapy on murine transitional cell carcinoma.
TLDR
Results indicate that local hyperthermia combined with doxorubicin hydrochloride, cis-platinum or cyclophosphamide can induce tumor regression, increase tumor doubling time and improve the survival of the tumor-bearing animal. Expand
New platinum antitumor complexes.
  • L. Kèlland
  • Medicine
  • Critical reviews in oncology/hematology
  • 1993
Over the past two decades, platinum-based drugs (cisplatin and, latterly, the less toxic analogue carboplatin) have conferred significant therapeutic benefit to a large number of cancer sufferers.Expand
...
1
2
3
4
5
...